Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Study of Ventricular Repolarization in Premature Ovarian Insufficiency and Influence of HRT
NCT04167033Recruiting
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Apr 2021
- Primary completion
- Apr 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of estradiol valerate + dydrogesterone in premature ovarian insufficiency (POI) (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Duration of QTc. Started Apr 2021; status: recruiting.
02
Drugs
estradiol valerate + dydrogesterone
03
Conditions
premature ovarian insufficiency (POI)
Beyond the preview
Go deeper on NCT04167033.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04167033.